Amrize Ltd · AMRZ · FY2026 Q2 · Calendar Q3 2026

Amrize raises guidance as project demand offsets cost pressure

Amrize's Q2 supports a constructive operating thesis: resilient demand from data centers, energy and infrastructure, combined with pricing actions, fuel surcharges and ASPIRE savings, helped sustain growth despite cost inflation. The main test is whether price realization and mix can protect margins as capacity investments ramp and volumes potentially moderate.

Reported After market closeNYSEBasic Materials $20.78B market cap
90quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.88 Consensus $0.95
EPS surprise -7.8% Reported versus consensus
Reported revenue $3.49B Consensus $3.37B
Revenue surprise +3.8% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -8.9% Event window
SPY move +0.6% Same window
Abnormal move -9.6% Stock minus SPY
Volume 3.4× Versus trailing sessions
Subsequent drift -6.0% Up to 20 sessions
AMRZSPY benchmark

Ask FN2 about AMRZ FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management raised full-year revenue and adjusted EBITDA guidance, while highlighting $29 million of Q2 ASPIRE savings, recent acquisitions and a broader capacity-expansion program. Cost inflation, price realization and the timing of Building Envelope margin improvement remained key areas of uncertainty.

Guidance delta

Management raised full-year revenue guidance to $12.5–$12.7 billion and adjusted EBITDA guidance to $3.1–$3.2 billion.

Key takeaways

  • Revenue grew 8.6%, including 6.7% organic growth, driven by demand from data centers, energy and infrastructure projects.
  • Oil, freight and diesel inflation remained a margin headwind; management cited pricing, fuel surcharges and ASPIRE savings as offsets.
  • The company reported $241 million of capex and highlighted capacity expansions, quarry development and recent acquisitions.
  • Management identified potential second-half volume moderation and continued uncertainty around price realization and mix.

Management priorities

  • Complete cement capacity expansions in Missouri, Quebec, Texas and Alberta.
  • Develop five aggregate quarries and build a Malarkey Shingles plant in Indiana.
  • Continue pursuing synergistic aggregates and concrete acquisitions.
  • Maintain the $1 billion share-repurchase program and dividend payouts.

Follow AMRZ with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
AMRZ EPS earnings history estimate and actual scatter chart 5 reported fiscal quarters and 4 future estimate-only quarters. Q2 '25 estimate $1.03 Q2 '25 actual $0.78, miss Q3 '25 estimate $1.02 Q3 '25 actual $1.06, beat Q4 '25 estimate $-0.13 Q4 '25 actual $-0.16, miss Q1 '26 estimate $-0.12 Q1 '26 actual $-0.16, miss Q2 '26 estimate $0.95 Q2 '26 actual $0.88, miss Q3 '26 estimate $1.09 Q4 '26 estimate $0.67 Q1 '27 estimate $-0.16 Q2 '27 estimate $0.98

Analyst Consensus ?

ConsensusHold9 ratings
Bullish333.3%
Neutral444.5%
Bearish222.2%

Analyst 52W Price Targets

$38.59Current
$40Low
$57.08Average
$75High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Oppenheimer Outperform OutperformMaintainSep 18, 2026
Wells Fargo Equal Weight OverweightDowngradeSep 9, 2026
JP Morgan Neutral OverweightDowngradeSep 2, 2026
B of A Securities Underperform NeutralDowngradeSep 2, 2026
Stephens & Co. Overweight OverweightMaintainAug 12, 2026
Citigroup Buy BuyMaintainAug 11, 2026
RBC Capital Underperform Sector PerformDowngradeAug 10, 2026
Truist Securities Hold BuyDowngradeJul 7, 2026
UBS Neutral NeutralMaintainJan 8, 2026
Show less

Named analyst price targets

Upside is calculated against the persisted current price $38.59. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
OppenheimerAnalyst unavailable$55$37.44 +42.5%Sep 18, 2026
Wells FargoAnalyst unavailable$44$41.95 +14.0%Sep 9, 2026
William BlairAnalyst unavailable$40$42.81 +3.7%Sep 2, 2026
D.A. DavidsonAnalyst unavailable$50$45.18 +29.6%Aug 24, 2026
StephensAnalyst unavailable$54$46.9 +39.9%Aug 12, 2026
RBC CapitalAnthony Codling$48$46.64 +24.4%Aug 10, 2026
Wells FargoAnalyst unavailable$58$50.94 +50.3%Jul 8, 2026
Truist FinancialKeith Hughes$48$54.01 +24.4%Jul 7, 2026
Morgan StanleyAnalyst unavailable$63$53.42 +63.3%Jun 22, 2026
Morgan StanleyAnalyst unavailable$65$54.48 +68.4%May 6, 2026
OppenheimerAnalyst unavailable$68$53.38 +76.2%May 1, 2026
Vertical ResearchAnalyst unavailable$70$53.78 +81.4%May 1, 2026
Wells FargoTimna Tanners$65$59.96 +68.4%Apr 15, 2026
Truist FinancialAnalyst unavailable$75$65 +94.4%Feb 20, 2026
OppenheimerAnalyst unavailable$70$63.7 +81.4%Feb 19, 2026
Wells FargoTimna Tanners$66$63.7 +71.0%Feb 19, 2026
Berenberg BankAnalyst unavailable$70$63.7 +81.4%Feb 19, 2026
Wells FargoAnalyst unavailable$59$53.64 +52.9%Jan 29, 2026
OppenheimerAnalyst unavailable$64$54.6 +65.8%Jan 15, 2026
Goldman SachsAnalyst unavailable$58$57.32 +50.3%Jan 12, 2026
BernsteinPujarini Ghosh$70$53.54 +81.4%Dec 18, 2025
RBC CapitalAnthony Codling$60$54.74 +55.5%Dec 8, 2025
Deutsche BankAnalyst unavailable$59$54.74 +52.9%Dec 8, 2025
Vertical ResearchMichael Dudas$54$50.13 +39.9%Nov 25, 2025
Morgan StanleyAnalyst unavailable$61$52.85 +58.1%Oct 29, 2025
UBSAnalyst unavailable$52$48.21 +34.7%Oct 14, 2025
Wells FargoTimna Tanners$57$47.13 +47.7%Oct 7, 2025
RBC CapitalAnthony Codling$54$47.02 +39.9%Aug 8, 2025
Berenberg BankAnalyst unavailable$64$49.55 +65.8%Jun 30, 2025
JefferiesAnalyst unavailable$52.5$49.01 +36.0%Jun 29, 2025
Truist FinancialAnalyst unavailable$60$53 +55.5%Jun 24, 2025
Show less

Track every rating change on AMRZ the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.

Basic Materials peers this season

Latest reports in the same sector
CompanyQuarterEPS surpriseMarket moveHeadline
HMY Harmony Gold Mining Company Limited FY2026 Q4 · Calendar Q3 2026 0.0% -6.2% Harmony Gold posts record FY2026 while Eva Copper risks remain

Latest beats and misses

Who reports next

Get the AMRZ recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-09T00:10:17.498009+00:00
  2. FN2 earnings calendar · 2026-09-11T01:23:15.000588+00:00
  3. Polygon adjusted daily market bars · 2026-09-21T22:20:47.435885+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-21T22:20:47.433037+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.